$JPM Options Intelligence

# JPM Options Analysis: Premium Selling Opportunity

🎯 SELL JPM MAR 20 300/295 PUT SPREAD

Stock Price: $295.62 | Entry: $0.95 credit

I recommend this put spread because the term structure reveals significantly overpriced near-term options, combined with JPM's technical setup showing support near current levels and fundamental strength supporting the banking sector.

---

## 📊 Trade Metrics

• Credit Received: $95
• Risk: $405 (if JPM closes below $295 at expiration)
• Reward: $95 (1.83% return on risk)
• Breakeven: $294.05
• Max Loss: $405 if JPM < $295 at expiry
• Max Profit: $95 if JPM > $300 at expiry
• Win Rate: 68% (based on delta)
• Days to Expiration: 18

---

## 📈 Term Structure & Volatility Analysis

This is the PRIMARY driver of this recommendation:

• Baseline 90-day Vol: 27.6%
• 14-day (Mar 20) Clean IV: 38.3% (38% ABOVE baseline = STRONG SELL signal)
• Market IV (Mar 20): 41.4% (overpriced relative to historical norms)
• 4-day (Mar 06) Clean IV: 61.5% (EXTREMELY overpriced)
• Earnings Multiplier: 1.91x (moderate - standard earnings volatility expected)

Key Insight: The 14-day expiration shows Clean IV at 38.3%, sitting 10.7% above the 27.6% baseline volatility. This indicates options are significantly overpriced relative to what JPM's historical volatility suggests. This creates an excellent premium-selling opportunity. The extreme overpricing in the 4-day expiration (61.5% Clean IV) suggests market is pricing in event risk from Non-Farm Payrolls on March 6 and CPI on March 11, but the Mar 20 expiration captures this premium decay without holding through the earnings announcement on April 10.

---

## 📈 Greeks & Volatility

• Net Delta: -0.32 (moderately bearish bias)
• Theta: $5.30/day (strong time decay working in your favor)
• Vega: -$12 (benefits significantly from IV compression)
• Current IV: 41.4% (elevated vs 27.9% historical)
• IV Rank: 61% (above average - premium-selling favored)
• Put/Call Ratio: 0.15 (extremely bullish - heavy call buying)

---

## 🎯 Why This Trade

The term structure analysis is definitive: 14-day Clean IV at 38.3% sits 10.7% above the 27.6% baseline volatility, indicating options are overpriced by nearly 40% relative to historical norms. This creates a statistical edge for selling premium.

Market Intelligence Context: JPMorgan Chase analysts recently predicted the U.S. CLARITY Act could be a major crypto catalyst mid-year, and the bank expects NII to increase by almost 9% in 2026[3][5]. The company is allocating $19.8 billion toward tech initiatives in 2026, demonstrating operational strength and investment confidence[3].

Technical Setup: JPM trades at $295.62, currently below its 20-day MA of $308.21 (down 4.1%), but RSI at 40.04 is neutral (not oversold). The stock is above its 200-day MA at $299.54, maintaining long-term support. The 300 strike sits just above the 20-day MA, providing natural resistance where the put spread short leg is protected.

Volatility Edge: The upcoming Non-Farm Payrolls (March 6) and CPI (March 11) will likely compress volatility into the Mar 20 expiration as uncertainty resolves. Your short puts benefit from this compression. Earnings on April 10 are safely AFTER this expiration, so you avoid earnings risk entirely.

Sector Strength: JPM's dividend yield of 1.96% with a $1.50 quarterly payment provides downside support. Related financials (C, WFC, MS, BAC, GS) show the sector remains resilient despite recent weakness.

---

## 📊 Pro Analysis

• Current IV: 41.4% vs Historical: 27.9%
• IV Rank: 61% (above average)
• Expected Daily Move: ±5.41 (1.83%)
• Put/Call Ratio: 0.15 (extremely bullish sentiment)
• Market Maker Max Pain: $340 (suggests upside bias)
• Technical: RSI 40 (neutral), Price 4.1% below 20MA, above 200MA (mixed)

---

## 🔍 Market Overview

The banking sector is navigating a complex environment: the Fed's current policy stance supports NII expansion (JPM expects 9% growth), but recent weakness suggests profit-taking after strong Q4 performance. The March 6 NFP and March 11 CPI reports create near-term uncertainty, explaining the elevated IV in the 4-6 day expirations. However, by March 20, these events will have resolved, likely compressing volatility.

JPM's fundamentals remain strong: EPS of $20.05, revenue of $182.45B, and a 31.3% profit margin demonstrate operational excellence. The stock's support near $295 (current price) and resistance at $308 (20-day MA) create a defined trading range. The 300/295 put spread targets this range perfectly.

Support Levels: $295 (current), $299.54 (200-day MA)
Resistance: $308.21 (20-day MA), $313.01 (50-day MA)

---

## 💡 Trade Management

• Entry: Place limit order for $0.95 credit (sell at $0.95-$1.00)
• Target: Close at $0.50 (47% profit on credit received)
• Stop: Exit if JPM breaks above $310 or if IV drops below